Abstract:Electronic cigarette, or vaping, products are used to heat an e-liquid to form an aerosol (liquid droplets suspended in gas) that the user inhales; a portion of this aerosol deposits in their respiratory tract and the remainder is exhaled, thereby potentially creating opportunity for secondhand exposure to bystanders (e.g., in homes, automobiles, and workplaces). Particle size, a critical factor in respiratory deposition (and therefore potential for secondhand exposure), could be influenced by e-liquid composition. Hence, the purposes of this study were to (1) test the influence of laboratory-prepared e-liquid composition [ratio of propylene glycol (PG) to vegetable glycerin (VG) humectants, nicotine, and flavorings] on particle size distribution and (2) model respiratory dosimetry. All e-liquids were aerosolized using a second-generation reference e-cigarette. We measured particle size distribution based on mass using a low-flow cascade impactor (LFCI) and size distribution based on number using real-time mobility sizers. Mass median aerodynamic diameters (MMADs) of aerosol from e-liquids that contained only humectants were significantly larger compared with e-liquids that contained flavorings or nicotine ( p = 0.005). Humectant ratio significantly influenced MMADs; all aerosols from e-liquids prepared with 70:30 PG:VG were significantly larger compared with e-liquids prepared with 30:70 PG:VG ( p = 0.017). In contrast to the LFCI approach, the high dilution and sampling flow rate of a fast mobility particle sizer strongly influenced particle size measurements (i.e., all calculated MMAD values were < 75 nm). Dosimetry modeling using LFCI data indicated that a portion of inhaled particles will deposit throughout the respiratory tract, though statistical differences in aerosol MMADs among e-liquid formulations did not translate into large differences in deposition estimates. A portion of inhaled aerosol will be exhaled and could be a source for secondhand exposure. Use of laboratory-prepared e-liquids and a reference e-cigarette to standardize aerosol generation and a LFCI to measure particle size distribution without dilution represents an improved method to characterize physical properties of volatile aerosol particles and permitted determination of MMAD values more representative of e-cigarette aerosol in situ , which in turn, can help to improve dose modeling for users and bystanders.

Computational transport, phase change and deposition analysis of inhaled multicomponent droplet–vapor mixtures in an idealized human upper lung model

Prediction of the transport, deposition, and absorption of multicomponent E-cigarette aerosols in a subject-specific mouth-to-G10 human respiratory system

Modeling of the Transport, Hygroscopic Growth, and Deposition of Multi-Component Droplets in a Simplified Airway with Realistic Thermal Boundary Conditions

Simulation of aerosol dynamics and deposition of combustible and electronic cigarette aerosols in the human respiratory tract

Evaporation and condensation of multicomponent electronic cigarette droplets and conventional cigarette smoke particles in an idealized G3–G6 triple bifurcating unit

In silico prediction of e-cigarette aerosol particle transport and deposition within the airways

Deposition of inhaled electronic cigarette aerosol in the human oral cavity

Computational Analysis of Deposition and Translocation of Inhaled Nicotine and Acrolein in the Human Body with E-Cigarette Puffing Topographies

Eulerian modeling of aerosol transport and deposition in respiratory tract under thermodynamic equilibrium condition

Numerical investigation of the interaction, transport and deposition of multicomponent droplets in a simple mouth-throat model

Influence of E-Liquid Humectants, Nicotine, and Flavorings on Aerosol Particle Size Distribution and Implications for Modeling Respiratory Deposition

Simulation of the phase change and deposition of inhaled semi-volatile liquid droplets in the nasal passages of rats and humans

In Silico Study on the Deposition and Distribution of Particles in a Realistic Airway Model with Handilaher®

Regional Aerosol Deposition in the Human Airways: the SimInhale Benchmark Case and a Critical Assessment of in Silico Methods

Size-change and deposition of conventional and composite cigarette smoke particles during inhalation in a subject-specific airway model

Numerical and Experimental Analysis of Drug Inhalation in Realistic Human Upper Airway Model

The effects of aerosol concentration on the evolution, transport, and deposition of hygroscopic droplets in the highly idealized MT model: A numerical study

Multispecies aerosol evolution and deposition in a human respiratory tract cast model

Aerodynamic particle size distribution and dynamic properties in aerosols from electronic cigarettes

Current Knowledge and Challenges of Particle Size Measurements of Mainstream E-Cigarette Aerosols and Their Implication on Respiratory Dosimetry